630 filings
Page 9 of 32
4
Sujay Kango
24 Jan 20
ACCELERON PHARMA / SUJAY KANGO ownership change
5:27pm
4
Mclaughlin Kevin F
24 Jan 20
ACCELERON PHARMA / KEVIN F MCLAUGHLIN ownership change
5:21pm
4
XLRN
Acceleron Pharma Inc
24 Jan 20
ACCELERON PHARMA / Habib J Dable ownership change
5:18pm
8-K
XLRN
Acceleron Pharma Inc
23 Jan 20
Departure of Directors or Certain Officers
4:20pm
4
XLRN
Acceleron Pharma Inc
9 Jan 20
ACCELERON PHARMA / Joseph S Zakrzewski ownership change
4:36pm
4
Veness Adam M
3 Jan 20
ACCELERON PHARMA / Adam M Veness ownership change
9:51pm
4
XLRN
Acceleron Pharma Inc
3 Jan 20
ACCELERON PHARMA / SUJAY KANGO ownership change
9:48pm
4
John D Quisel
3 Jan 20
ACCELERON PHARMA / John D Quisel ownership change
9:45pm
4
XLRN
Acceleron Pharma Inc
3 Jan 20
ACCELERON PHARMA / KEVIN F MCLAUGHLIN ownership change
9:41pm
4
XLRN
Acceleron Pharma Inc
3 Jan 20
ACCELERON PHARMA / Habib J Dable ownership change
9:37pm
4
XLRN
Acceleron Pharma Inc
3 Jan 20
ACCELERON PHARMA / Jay T. Backstrom ownership change
9:32pm
4
Kemal Malik
3 Jan 20
ACCELERON PHARMA / Kemal Malik ownership change
9:24pm
3
XLRN
Acceleron Pharma Inc
3 Jan 20
ACCELERON PHARMA / Kemal Malik ownership change
9:20pm
4
XLRN
Acceleron Pharma Inc
17 Dec 19
ACCELERON PHARMA / KEVIN F MCLAUGHLIN ownership change
6:39pm
3
Jay T. Backstrom
17 Dec 19
ACCELERON PHARMA / Jay T. Backstrom ownership change
6:19pm
8-K
XLRN
Acceleron Pharma Inc
13 Dec 19
Other Events
4:35pm
8-K
XLRN
Acceleron Pharma Inc
9 Dec 19
Other Events
8:04am
8-K
XLRN
Acceleron Pharma Inc
6 Dec 19
Departure of Directors or Certain Officers
5:26pm
SC 13G/A
T. Rowe Price Group Inc.
12 Nov 19
Acceleron Pharma Inc
10:16am
8-K
XLRN
Acceleron Pharma Inc
8 Nov 19
REBLOZYL is the first and only FDA-approved erythroid maturation agent, representing a new class of therapy for these patients
5:27pm